查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2126535

醫用拋棄式產品：市場洞察、競爭格局及市場預測 - 2034 年

Medical Disposable Products - Market Insights, Competitive Landscape, and Market Forecast - 2034
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

概述：

  • 預計到 2025 年，醫療拋棄式產品市場規模將達到 5,045 億美元，到 2034 年將達到 9,167 億美元。這一成長是由外科手術和診斷程序數量的增加、所有醫療機構感染控制規程的加強以及全球醫院和門診手術設施基礎設施的擴建所推動的。
  • 全球拋棄式產品市場預計在 2026 年至 2034 年的預測期內將以 6.65% 的複合年成長率成長。
  • 按產品類型分類，預計到 2025 年，拋棄式手套市場佔有率將達到 28%，從而推動醫療拋棄式產品市場的發展。
  • 按材料分類，預計到 2025 年，塑膠製品將佔 46% 的市場佔有率，主導醫療拋棄式產品市場。
  • 就滅菌狀態而言，「已滅菌」部分預計將推動醫療拋棄式產品市場的發展，到 2025 年將佔市場佔有率的 68%。
  • 按應用領域分類，預計到 2025 年，感染控制領域將引領醫療拋棄式產品市場，佔 33% 的市場佔有率。
  • 按最終用戶分類，預計到 2025 年，醫院領域將主導醫療拋棄式產品市場，佔市場佔有率的 58%。
  • 預計到 2025 年，北美將以 40% 的銷售額引領全球醫療拋棄式產品市場，在全球區域市場佔有率中佔最高地位。

拋棄式產品是指設計為一次性使用的醫療設備或耗材，包括注射器、針頭、手套、輸液器、外科用覆蓋巾、傷口敷料和導尿管等，旨在最大限度地降低交叉感染和院內感染（HAI）的風險。由於可重複使用的器械需要高成本的消毒流程，因此存在殘留感染風險，並且無法滿足現代外科手術、診斷和重症監護中日益成長的操作量，因此，世界各地的醫院、門診手術中心和診斷檢查室在日常護理和緊急護理中都高度依賴拋棄式產品。這些產品廣泛應用於藥物給藥和輸注、血液採集和輸血、呼吸防護、傷口處理、外科手術和泌尿系統護理等領域。市場按產品類型細分為拋棄式注射器和針頭、靜脈注射輸液產品、血液採集和輸血產品、拋棄式手套、外科口罩和拋棄式產品、外科用覆蓋巾和罩衣、創傷護理和敷料產品以及一次性泌尿系統拋棄式產品。依材料進一步細分為塑膠、橡膠和乳膠、不織布、紙和紙板以及玻璃。此外，按無菌狀態細分為無菌和非無菌，按應用領域細分為外科手術、感染控制、藥物和輸液、傷口管理、診斷和臨床檢測、血液採集和輸血以及呼吸護理。醫院是主要終端用戶。在外科手術和診斷數量的增加、感染控制標準的日益嚴格、老齡化社會慢性病負擔加重以及門診和護理系統不斷擴張的推動下，拋棄式產品已成為支撐安全高效患者照護的重要基礎設施。

醫療拋棄式產品市場的主要成長促進因素

  • 隨著全球外科手術和診斷程序的增加，拋棄式注射器、外科用覆蓋巾、手術罩衣和手術包的消耗量也直接增加，因為醫院和門診手術中心每年都要接待更多的病人。
  • 為因應 COVID-19 疫情，加強感染控制標準促使醫院、診所和檢查室對拋棄式手套、口罩和拋棄式產品的基本需求持續增加。
  • 隨著全球慢性疾病和感染疾病負擔的加重，對靜脈注射和輸血耗材、創傷護理和敷料產品的需求不斷成長，尤其是在老齡化人口中。
  • 門診手術中心和門診診所的快速擴張，使得拋棄式產品的最終用戶群體不再局限於傳統的醫院基礎設施。
  • 包括 FDA 和 EMA 在內的監管機構不斷收緊外科手術、藥物管理和血液處理應用中拋棄式無菌產品的要求，從而支持了對符合標準的拋棄式產品的需求。
  • 包括 BD 和 Molnlycke Health Care 在內的領先製造商正在投資數億美元用於提高注射器、針頭和創傷護理產品的國內生產能力，從而加強其區域分散且可靠的供應鏈。
  • 手術量增加、感染控制標準提高、慢性病負擔加重以及門診護理服務擴展等因素預計將推動市場持續成長至 2034 年。

推動醫療拋棄式產品市場成長的因素

市場促進因素

手術和診斷程序數量增加

醫療拋棄式產品市場最持續的促進因素是全球醫院和門診手術中心所進行的外科手術和診斷程序數量的穩定成長。從常規門診手術到複雜的住院手術，每項手術都需要使用拋棄式注射器、針頭、手術鋪巾、罩衣和手術包，這些物品均設計為一次性使用，以消除交叉感染的風險。隨著人口老化以及心血管疾病、糖尿病和癌症等慢性疾病盛行率的上升，診斷性檢查、微創手術和外科手術的頻率也增加。門診手術中心正逐漸取代傳統上在醫院進行的擇期手術，隨著醫療服務場所的增加，拋棄式產品的需求也逐漸增加。由於在外科手術和診斷環境中保持無菌和堅持一次性使用至關重要，因此，手術數量的成長將直接且持續地推動拋棄式產品消費量的成長，直至2034年。

加強感染控制標準

新冠疫情永久改變了整個醫療保健產業對感染預防的基本預期。這些更高的標準持續推動對拋棄式手套、外科口罩和拋棄式產品的需求。與疫情前相比，醫院、診所、檢查室和長期護理機構已將增加手套更換頻率、在特定環境下普遍佩戴口罩以及更嚴格地使用個人防護設備(PPE) 等措施制度化。監管機構和認證機構不斷加強感染控制合規性，將其作為醫院認證和保險報銷的條件，這使得拋棄式PPE 的消耗量持續高於歷史水平。隨著新興市場醫療保健系統建立符合全球標準的感染控制基礎設施，這種需求促進因素已遍及全球，預計將在整個預測期內保持需求成長。

市場限制因素

儘管潛在需求強勁，但拋棄式產品市場仍面臨許多限制因素。人們對拋棄式塑膠廢棄物的環境問題日益關注，導致監管力度加大，部分地區甚至徵收生產者延伸責任制（EPR）費用，迫使製造商在不影響無菌性和成本的前提下，開發可生物分解和可回收的替代品。激烈的市場競爭和報銷壓力正在擠壓利潤空間，尤其是在手套和注射器等商品化產品領域，這使得規模更大、成本更低的生產商比小規模的區域生產商更具優勢。原料價格波動，包括塑膠、丁腈橡膠和乳膠，源自於石化產品價格波動和供應中斷，為整個價值鏈帶來了成本不確定性。在價格敏感的市場中，低價、有時甚至是仿冒品或不合格的一次性拋棄式產品氾濫，引發了人們對產品品質和病人安全的擔憂，使符合監管要求的製造商面臨更加複雜的競爭環境。複雜的跨境法規核准和滅菌驗證要求延長了產品開發週期，並推高了合規成本。同時，間歇性的供應鏈中斷，例如疫情期間手套和個人防護裝備的短缺，並持續暴露原料和成品生產地理集中帶來的風險。儘管外科手術量增加、感染控制以及慢性病負擔等潛在成長動力依然強勁，但環境、價格、品質、監管和供應鏈等多重成長要素共同作用，正在減緩經濟成長步伐。

目錄

第1章：醫療拋棄式產品市場：引言

  • 調查範圍
  • 市場區隔
  • 市場先決條件

第2章：醫療拋棄式產品市場：摘要整理

  • 市場概覽

第3章：醫用拋棄式產品市場：關鍵因素分析

  • 醫用拋棄式產品市場：市場促進因素
    • 手術和診斷治療數量增加
    • 更嚴格的感染控制標準
    • 慢性病負擔日益加重和人口老化
    • 擴大門診手術中心及門診服務
  • 醫用拋棄式產品市場：限制因素與挑戰
    • 有關環境問題和塑膠廢棄物的法規
    • 競爭與還款壓力
    • 原物料價格波動與供應鏈風險
  • 醫用拋棄式產品市場：市場機遇
    • 永續和可生物分解材料的創新
    • 新興市場製造業和分銷業的擴張

第4章：人工智慧、地緣政治、貿易與經濟趨勢

第5章：監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第6章：波特五力分析

第7章：醫用拋棄式產品市場：評估

  • 依產品類型
    • 拋棄式注射器和針頭
    • 靜脈注射和輸液產品
    • 血液採集及輸血用產品
    • 拋棄式手套
    • 外科口罩和拋棄式產品
    • 外科用覆蓋巾及罩衣
    • 創傷護理和敷料產品
    • 泌尿系統系統拋棄式產品
    • 其他
  • 材料
    • 塑膠
    • 橡膠和乳膠
    • 不織布材料
    • 紙張和紙板
    • 玻璃
  • 按滅菌狀態
    • 已滅菌
    • 非無菌
  • 用途別
    • 外科手術
    • 感染控制
    • 藥物輸送和輸液
    • 傷口管理
    • 診斷和臨床測試
    • 採血/輸血
    • 呼吸護理
  • 最終用戶
    • 醫院
    • 門診手術中心
    • 診所和私人診所
    • 診斷與研究機構
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 世界其他地區

第8章：醫用拋棄式產品市場：競爭格局

  • 市場集中度與結構
  • 競爭定位與市場佔有率分析（加值服務）

第9章：醫療拋棄式產品市場：新創企業資金籌措與投資趨勢

第10章 醫用拋棄式產品市場：公司概況與產品概況

  • Becton, Dickinson and Company（BD）
  • Cardinal Health
  • Medline Industries, Inc.
  • 3M Company
  • Medtronic plc
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Terumo Corporation
  • Nipro Corporation
  • Molnlycke Health Care AB

第11章：KOL的觀點

第12章：專案式教學方法

第13章：關於 DelveInsight

第14章 免責聲明與聯絡方式

Product Code: DIMDCL0999

Medical Disposable Products Market Summary

Overview:

  • The Medical Disposable Products market is estimated at USD 504.5 billion in 2025 and is projected to reach USD 916.7 billion by 2034. Growth is anchored in rising surgical and diagnostic procedure volumes, intensifying infection-control protocols across care settings, and expanding hospital and ambulatory surgical infrastructure worldwide.
  • The global Medical Disposable Products market is growing at a CAGR of 6.65% during the forecast period from 2026 to 2034.
  • By product type, the disposable gloves segment dominated the Medical Disposable Products market with a 28% share in 2025.
  • By material, the plastic segment dominated the Medical Disposable Products market with a 46% share in 2025.
  • By sterility, the sterile segment dominated the Medical Disposable Products market with a 68% share in 2025.
  • By application, the infection control segment dominated the Medical Disposable Products market with a 33% share in 2025.
  • By end-users, the hospitals segment dominated the Medical Disposable Products market with a 58% share in 2025.
  • North America dominated the global Medical Disposable Products market revenue with a 40% share in 2025, representing the highest regional market share globally.

A medical disposable product is a single-use device or consumable, ranging from syringes, needles, gloves, and IV sets to surgical drapes, wound dressings, and urinary catheters, that is designed to be used once and discarded to minimize the risk of cross-contamination and hospital-acquired infections (HAIs). Because reusable instruments require costly sterilization cycles, carry residual infection risk, and cannot always keep pace with the volume of modern surgical, diagnostic, and critical-care procedures, hospitals, ambulatory surgical centers, and diagnostic laboratories worldwide rely heavily on disposable products for routine and high-acuity care. These products span drug delivery and infusion, blood collection and transfusion, respiratory protection, wound management, surgical procedures, and urological care. The market is organized by product type across disposable syringes and needles, IV and infusion products, blood collection and transfusion products, disposable gloves, surgical masks and respiratory disposables, surgical drapes and gowns, wound care and dressing products, and urinary and urological disposables; by material across plastic, rubber and latex, nonwoven materials, paper and paperboard, and glass; by sterility across sterile and non-sterile; by application across surgical procedures, infection control, drug delivery and infusion, wound management, diagnostic and laboratory testing, blood collection and transfusion, and respiratory care; and by end-users, led by hospitals. Driven by rising surgical and diagnostic volumes, heightened infection-control standards, an aging population with growing chronic disease burden, and continued expansion of outpatient and ambulatory care capacity, medical disposable products have become foundational infrastructure underpinning safe, efficient patient care delivery.

Medical Disposable Products Market Key Growth Drivers

  • Rising global surgical and diagnostic procedure volumes are directly increasing consumption of disposable syringes, drapes, gowns, and procedure kits, with hospitals and ambulatory surgical centers processing higher patient throughput each year.
  • Heightened infection-control standards following the COVID-19 pandemic have permanently elevated baseline demand for single-use gloves, masks, and respiratory disposables across hospitals, clinics, and diagnostic laboratories.
  • The rising global burden of chronic and infectious disease is expanding demand for IV and infusion products, blood collection and transfusion consumables, and wound care and dressing products, particularly among aging populations.
  • The rapid growth of ambulatory surgical centers and outpatient care settings is broadening the end-user base for disposable products beyond traditional hospital infrastructure.
  • Regulatory bodies including the FDA and EMA continue to reinforce single-use, sterile-product requirements in surgical, drug-delivery, and blood-handling applications, sustaining demand for compliant disposables.
  • Leading manufacturers, including BD and Molnlycke Health Care, are investing hundreds of millions of dollars in domestic manufacturing capacity for syringes, needles, and wound care products, reinforcing reliable, regionally distributed supply.
  • The convergence of rising procedure volumes, infection-control standards, chronic disease burden, and outpatient care expansion is expected to sustain steady growth in the market through 2034.

Key Companies in Medical Disposable Products Market

The competitive landscape is led by the following active manufacturers:

  • Becton, Dickinson and Company (BD)
  • Cardinal Health
  • Medline Industries, Inc.
  • 3M Company
  • Medtronic plc
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Terumo Corporation
  • Nipro Corporation
  • Molnlycke Health Care AB

Factors Contributing to the Growth of the Medical Disposable Products Market

Market Drivers

Rising Surgical and Diagnostic Procedure Volumes

The most consistent driver of the Medical Disposable Products market is the steady global rise in surgical and diagnostic procedure volumes across hospitals and ambulatory surgical centers. Each procedure, from routine outpatient interventions to complex inpatient surgeries, consumes disposable syringes, needles, drapes, gowns, and procedure kits designed for single use to eliminate cross-contamination risk. As populations age and the prevalence of chronic conditions such as cardiovascular disease, diabetes, and cancer increases, the frequency of diagnostic testing, minimally invasive procedures, and surgical interventions rises in parallel. Ambulatory surgical centers are absorbing a growing share of elective procedures previously performed in hospitals, and each new site of care represents incremental disposable-product demand. Because sterility and single-use compliance are non-negotiable in surgical and diagnostic settings, this procedural growth translates directly and durably into rising disposable-product consumption through 2034.

Heightened Infection-Control Standards

The COVID-19 pandemic permanently reset baseline expectations for infection prevention across healthcare, and this elevated standard continues to drive demand for disposable gloves, surgical masks, and respiratory disposables. Hospitals, clinics, diagnostic laboratories, and long-term care facilities have institutionalized higher glove-change frequency, universal masking protocols in select settings, and stricter personal protective equipment (PPE) usage than in the pre-pandemic era. Regulatory and accreditation bodies continue to reinforce infection-control compliance as a condition of hospital accreditation and reimbursement, keeping single-use PPE consumption structurally higher than historical norms. As healthcare systems in emerging markets upgrade infection-control infrastructure to align with global standards, this driver is expected to broaden geographically and sustain demand growth across the forecast period.

Market Restraints

Despite strong underlying demand, the Medical Disposable Products market faces material constraints. Mounting environmental concern over single-use plastic waste is drawing regulatory scrutiny, including extended producer responsibility (EPR) fees in several jurisdictions, and is pressuring manufacturers to develop biodegradable and recyclable alternatives without compromising sterility or cost. Intense price competition and reimbursement pressure, particularly in commoditized categories such as gloves and syringes, compress margins and favor large-scale, low-cost producers over smaller regional players. Raw material price volatility in plastics, nitrile, and latex, driven by petrochemical price swings and supply disruptions, creates cost unpredictability across the value chain. The proliferation of low-cost, and in some cases counterfeit or substandard, disposable products in price-sensitive markets raises quality and patient-safety concerns and complicates competitive dynamics for compliant manufacturers. Complex, cross-border regulatory approval and sterilization-validation requirements lengthen product development timelines and raise compliance costs, while episodic supply chain disruptions, as seen during the pandemic-era glove and PPE shortages, continue to expose the risks of geographic concentration in raw material and finished-goods production. Together, these environmental, pricing, quality, regulatory, and supply chain pressures temper the pace of growth, even as the underlying drivers of procedure volume, infection control, and chronic disease burden remain firmly intact.

Medical Disposable Products Market Segment Analysis

The medical disposable products market by product type (disposable syringes & needles, iv & infusion products, blood collection & transfusion products, disposable gloves, surgical masks & respiratory disposables, surgical drapes & gowns, wound care & dressing products, urinary & urological disposables, and others), material (plastic, rubber & latex, nonwoven materials, paper & paperboard, glass, and others), sterility (sterile and non-sterile), application (surgical procedures, infection control, drug delivery & infusion, wound management, diagnostic & laboratory testing, blood collection & transfusion, respiratory care, others), end-users (hospitals, ambulatory surgical centers, clinics & physician offices, diagnostic & research laboratories, and others), and geography (North America, Europe, Asia-Pacific, and Rest of World).

By Product Type

Dominant Subsegment: Disposable Gloves.

The disposable gloves segment accounted for 28% of the Medical Disposable Products market in 2025. Disposable gloves are the leading product type because they are used at the highest frequency of any disposable category, with hospital and clinical staff changing gloves for nearly every patient interaction across surgical, diagnostic, and routine care settings. Elevated post-pandemic infection-control protocols, combined with strict regulatory requirements around barrier protection in surgical and examination settings, sustain exceptionally high, recurring consumption. Nitrile gloves continue to gain share over natural rubber latex amid allergy concerns and supply diversification, while manufacturers expand domestic production capacity to reduce reliance on concentrated Southeast Asian supply. While disposable syringes and needles and wound care and dressing products post strong growth on the back of rising injectable therapy volumes and chronic wound prevalence, the sheer frequency and universality of glove usage across every care setting secure the segment's leadership across the forecast period.

By Material

Dominant Subsegment: Plastic.

The plastic segment accounted for 46% of the Medical Disposable Products market in 2025. Plastic is the leading material because it underpins the vast majority of disposable syringes, IV and infusion sets, urinary catheters, and packaging components, offering a favorable balance of cost, moldability, chemical inertness, and compatibility with sterilization processes such as ethylene oxide and gamma irradiation. Polypropylene and polyvinyl chloride remain the workhorse polymers for tubing, syringe barrels, and fluid-contact components across nearly every disposable product category. Nonwoven materials are growing quickly on the back of surgical drape, gown, and mask demand, and rubber and latex remain essential for gloves, but the breadth of plastic's application across the widest range of disposable product categories secures its leadership across the forecast period, even as manufacturers face growing pressure to develop bio-based and recyclable plastic alternatives.

Medical Disposable Products Market Region Analysis

Dominant Region: North America

North America accounted for 40% of the global Medical Disposable Products market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects advanced, well-funded healthcare infrastructure, high per-capita healthcare spending, a dense concentration of hospitals and ambulatory surgical centers, and a strong regulatory framework anchored by the FDA. The United States hosts the largest concentration of leading manufacturers and distributors, including BD, Cardinal Health, Medline, and 3M, and continued domestic manufacturing investment, including BD's multi-billion-dollar U.S. capacity expansion, reinforces regional supply resilience. High surgical and diagnostic procedure volumes, an aging population with rising chronic disease burden, and stringent infection-control standards across hospitals and clinics sustain substantial disposable-product demand. Strong reimbursement frameworks and continued build-out of ambulatory surgical capacity anchor the region's continued leadership across the forecast period.

Fastest Growing Region: Asia-Pacific

Asia-Pacific is the fastest-growing region in the Medical Disposable Products market. The region's elevated CAGR is driven by rapid expansion of hospital and diagnostic infrastructure, rising healthcare expenditure, and growing surgical and procedural volumes across China, Japan, India, South Korea, and Australia. China continues to expand hospital bed capacity and domestic disposable-product manufacturing, India benefits from low-cost production and growing insurance penetration that is expanding access to surgical and diagnostic care, and Japan's aging population is driving sustained demand for wound care, infusion, and urological disposables. Government healthcare investment, expanding medical insurance coverage, and rising local and export manufacturing of gloves, syringes, and PPE position Asia-Pacific as the principal source of incremental growth over the forecast period.

Regional Commentary

North America

North America accounted for 40% of the global Medical Disposable Products market revenue in 2025. The United States dominates on the strength of its advanced hospital and ambulatory surgical infrastructure, high healthcare spending, and concentration of leading manufacturers, while continued domestic capacity investment by BD, Molnlycke, and other major players reinforces the region's supply resilience and leadership.

Europe

Europe is a large and advanced regional market, supported by established EMA regulatory frameworks, strong public healthcare systems, and growing wound care and infusion manufacturing capacity. Investment activity such as Molnlycke's expanded manufacturing footprint across Finland and the United Kingdom, and B. Braun's continued growth in eco-friendly syringe and infusion production, reinforce the region's role in supplying both hospital and outpatient care across Germany, France, the United Kingdom, Italy, and Spain.

Asia-Pacific

Asia-Pacific is the fastest-growing region, propelled by rising healthcare investment, expanding hospital and diagnostic infrastructure, and growing surgical and procedural volumes across China, Japan, India, South Korea, and Australia. China's expanding domestic manufacturing base, Molnlycke's new wound care site in Changshu, India's low-cost production and rising insurance penetration, and Japan's aging-population-driven demand for infusion and urological disposables are accelerating regional growth.

Rest of World

The Rest of World region, spanning Latin America, the Middle East, and Africa, is an emerging growth frontier. Expanding hospital and healthcare infrastructure, rising demand for basic surgical and infection-control supplies, and efforts to align local regulatory frameworks with global GMP and sterility standards are gradually broadening access, while growing local manufacturing and international distribution partnerships support the build-out of regional supply capacity.

Medical Disposable Products Market Competitive Landscape

The Medical Disposable Products market is classified as Fragmented. A group of large, diversified manufacturers and distributors with global scale and broad product portfolios, including Becton, Dickinson and Company, Cardinal Health, Medline Industries, and 3M Company, anchor the top tier, while specialized and category-focused players such as Baxter International, B. Braun Melsungen, Terumo Corporation, Nipro Corporation, and Molnlycke Health Care compete through deep expertise in specific product categories such as infusion therapy, syringes and needles, and advanced wound care, increasing competition across individual product segments.

The competitive landscape can be evaluated across the following dimensions:

  • Market concentration: Fragmented, with large diversified manufacturers and distributors leading and a broad field of category-specialized players competing on product depth and regional reach.
  • Leading players: Becton, Dickinson and Company, Cardinal Health, Medline Industries, and 3M Company anchor the top tier through manufacturing scale and broad product portfolios.
  • Geographic reach: Leaders operate global, regionally distributed manufacturing and distribution networks; Medline offers approximately 190,000 med-surg products across its Front Line Care, Surgical Solutions, and Laboratory and Diagnostics categories.
  • Product portfolio strength: Top players offer end-to-end portfolios spanning syringes and needles, infusion products, gloves, respiratory disposables, drapes and gowns, wound care, and urological disposables.
  • Manufacturing capacity: Ownership of domestic and regionally distributed manufacturing capacity, including BD's committed USD 2.5 billion U.S. manufacturing investment, is a decisive competitive advantage.
  • Strategic partnerships and acquisitions: Active category consolidation, including Cardinal Health's acquisition of Advanced Diabetes Supply Group and Molnlycke's agreement to acquire wound-cleansing manufacturer P.G.F. Industry Solutions, extends category depth.
  • Innovation focus: Advanced wound care technologies, low-dead-space and safety-engineered syringes, smart and connected disposables, and sustainable, low-waste, and biodegradable materials.

Medical Disposable Products Market Recent Developmental Activities

In April 2026, BD (Becton, Dickinson and Company) launched its AI-enabled Pyxis Pro Dispensing Solution and Incada Connected Care Platform in the European market, extending automated medication management and connected-care capabilities beyond the United States. Strategic significance: Expands BD's connected-care and medication-management footprint in Europe.

In February 2026, BD (Becton, Dickinson and Company) launched the BD Vacutainer Urine Complete Cup Kit, a three-tube collection system designed to expand testing capabilities and reduce repeat specimen collection. Strategic significance: Strengthens BD's diagnostic and specimen-collection disposables portfolio.

In January 2026, BD (Becton, Dickinson and Company) announced a USD 110 million investment to expand BD Neopak glass prefillable syringe and cannula production at its Columbus, Nebraska facility, part of a broader commitment exceeding USD 2.5 billion in U.S. manufacturing upgrades over five years. Strategic significance: Reinforces domestic prefillable syringe supply resilience for biologic and injectable drug delivery.

Medical Disposable Products Market Segmentation

Medical Disposable Products Market by Product Type

  • Disposable Syringes & Needles
  • IV & Infusion Products
  • Blood Collection & Transfusion Products
  • Disposable Gloves
  • Surgical Masks & Respiratory Disposables
  • Surgical Drapes & Gowns
  • Wound Care & Dressing Products
  • Urinary & Urological Disposables
  • Others

Medical Disposable Products Market by Material

  • Plastic
  • Rubber & Latex
  • Nonwoven Materials
  • Paper & Paperboard
  • Glass
  • Others

Medical Disposable Products Market by Sterility

  • Sterile
  • Non-Sterile

Medical Disposable Products Market by Application

  • Surgical Procedures
  • Infection Control
  • Drug Delivery & Infusion
  • Wound Management
  • Diagnostic & Laboratory Testing
  • Blood Collection & Transfusion
  • Respiratory Care
  • Others

Medical Disposable Products Market by End-Users

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics & Physician Offices
  • Diagnostic & Research Laboratories
  • Others

Medical Disposable Products Market by Geography

  • North America Medical Disposable Products Market
  • United States Medical Disposable Products Market Size in USD million (2023-2034)
  • Canada Medical Disposable Products Market Size in USD million (2023-2034)
  • Mexico Medical Disposable Products Market Size in USD million (2023-2034)
  • Europe Medical Disposable Products Market
  • Germany Medical Disposable Products Market Size in USD million (2023-2034)
  • United Kingdom Medical Disposable Products Market Size in USD million (2023-2034)
  • France Medical Disposable Products Market Size in USD million (2023-2034)
  • Italy Medical Disposable Products Market Size in USD million (2023-2034)
  • Spain Medical Disposable Products Market Size in USD million (2023-2034)
  • Rest of Europe Medical Disposable Products Market Size in USD million (2023-2034)
  • Asia-Pacific Medical Disposable Products Market
  • China Medical Disposable Products Market Size in USD million (2023-2034)
  • Japan Medical Disposable Products Market Size in USD million (2023-2034)
  • India Medical Disposable Products Market Size in USD million (2023-2034)
  • Australia Medical Disposable Products Market Size in USD million (2023-2034)
  • South Korea Medical Disposable Products Market Size in USD million (2023-2034)
  • Rest of Asia-Pacific Medical Disposable Products Market Size in USD million (2023-2034)
  • Rest of the World (RoW) Medical Disposable Products Market
  • Middle East Medical Disposable Products Market Size in USD million (2023-2034)
  • Africa Medical Disposable Products Market Size in USD million (2023-2034)
  • South America Medical Disposable Products Market Size in USD million (2023-2034)

Key Takeaways from the Medical Disposable Products Market Report Study

  • Market size analysis for the current Medical Disposable Products market size (2025), and market forecast for 9 years (2026 to 2034).
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures that happened over the last 3 years.
  • Key companies dominating the global Medical Disposable Products market.
  • Various opportunities available for competitors in the Medical Disposable Products market space.
  • What are the top-performing segments in 2025? How will these segments perform in 2034?
  • Which are the top-performing regions and countries in the current Medical Disposable Products market scenario?
  • Which are the regions and countries where companies should concentrate their opportunities for Medical Disposable Products market growth in the future?

Target audience who can benefit from this Medical Disposable Products market report study

  • Medical Disposable Products product providers
  • Research organizations and consulting companies
  • Medical Disposable Products -related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in Medical Disposable Products
  • Various end-users who want to know more about the Medical Disposable Products market and the latest technological developments in the Medical Disposable Products market.

Frequently Asked Questions:

Q1. What is the growth rate of the Medical Disposable Products market?

The Medical Disposable Products market is projected to expand at a CAGR of 6.65% during the forecast period from 2026 to 2034.

Q2. What is the market size of the Medical Disposable Products market?

The Medical Disposable Products market is estimated at USD 504.5 billion in 2025 and is projected to reach USD 916.7 billion by 2034.

Q3. Which region dominates the Medical Disposable Products market?

North America dominated the Medical Disposable Products market with a 40% share of global revenue in 2025, supported by advanced healthcare infrastructure, high per-capita healthcare spending, a dense concentration of hospitals and ambulatory surgical centers, and stringent FDA regulatory standards. Asia-Pacific is the fastest-growing region over the forecast period.

Q4. What are the key drivers of the Medical Disposable Products market?

The principal drivers are rising global surgical and diagnostic procedure volumes; heightened infection-control standards following the COVID-19 pandemic; the rising global burden of chronic disease and an aging population expanding demand for infusion, blood collection, and wound care products; growth of ambulatory surgical centers and outpatient care; and continued regulatory reinforcement of single-use, sterile-product requirements.

Q5. Who are the major players in the Medical Disposable Products market?

The major players include Becton, Dickinson and Company (BD), Cardinal Health, Medline Industries, Inc., 3M Company, Medtronic plc, Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, and Molnlycke Health Care AB, among other active providers profiled in the Competitive Landscape section.

Table of Contents

1. Medical Disposable Products Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumptions

2. Medical Disposable Products Market Executive Summary

  • 2.1 Market at a Glance

3. Medical Disposable Products Market Key Factors Analysis

  • 3.1 Medical Disposable Products Market Drivers
    • 3.1.1 Rising Surgical and Diagnostic Procedure Volumes
    • 3.1.2 Heightened Infection-Control Standards
    • 3.1.3 Expanding Chronic Disease Burden and Aging Population
    • 3.1.4 Growth of Ambulatory Surgical Centers and Outpatient Care
  • 3.2 Medical Disposable Products Market Restraints and Challenges
    • 3.2.1 Environmental Concerns and Plastic Waste Regulation
    • 3.2.2 Price Competition and Reimbursement Pressure
    • 3.2.3 Raw Material Volatility and Supply Chain Risk
  • 3.3 Medical Disposable Products Market Opportunities
    • 3.3.1 Sustainable and Biodegradable Material Innovation
    • 3.3.2 Emerging-Market Manufacturing and Distribution Expansion

4. Impact Analysis: AI, Geopolitical, Trade, and Economic Developments

5. Regulatory Analysis

  • 5.1 United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Medical Disposable Products Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Buyers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Medical Disposable Products Market Assessment

  • 7.1 By Product Type
    • 7.1.1 Disposable Syringes & Needles
    • 7.1.2 IV & Infusion Products
    • 7.1.3 Blood Collection & Transfusion Products
    • 7.1.4 Disposable Gloves
    • 7.1.5 Surgical Masks & Respiratory Disposables
    • 7.1.6 Surgical Drapes & Gowns
    • 7.1.7 Wound Care & Dressing Products
    • 7.1.8 Urinary & Urological Disposables
    • 7.1.9 Others
  • 7.2 By Material
    • 7.2.1 Plastic
    • 7.2.2 Rubber & Latex
    • 7.2.3 Nonwoven Materials
    • 7.2.4 Paper & Paperboard
    • 7.2.5 Glass
    • 7.2.6 Others
  • 7.3 By Sterility
    • 7.3.1 Sterile
    • 7.3.2 Non-Sterile
  • 7.4 By Application
    • 7.4.1 Surgical Procedures
    • 7.4.2 Infection Control
    • 7.4.3 Drug Delivery & Infusion
    • 7.4.4 Wound Management
    • 7.4.5 Diagnostic & Laboratory Testing
    • 7.4.6 Blood Collection & Transfusion
    • 7.4.7 Respiratory Care
    • 7.4.8 Others
  • 7.5 By End-Users
    • 7.5.1 Hospitals
    • 7.5.2 Ambulatory Surgical Centers
    • 7.5.3 Clinics & Physician Offices
    • 7.5.4 Diagnostic & Research Laboratories
    • 7.5.5 Others
  • 7.6 By Geography
    • 7.6.1 North America
      • 7.6.1.1 United States Medical Disposable Products Market Size in USD million (2023-2034)
      • 7.6.1.2 Canada Medical Disposable Products Market Size in USD million (2023-2034)
      • 7.6.1.3 Mexico Medical Disposable Products Market Size in USD million (2023-2034)
    • 7.6.2 Europe
      • 7.6.2.1 Germany Medical Disposable Products Market Size in USD million (2023-2034)
      • 7.6.2.2 United Kingdom Medical Disposable Products Market Size in USD million (2023-2034)
      • 7.6.2.3 France Medical Disposable Products Market Size in USD million (2023-2034)
      • 7.6.2.4 Italy Medical Disposable Products Market Size in USD million (2023-2034)
      • 7.6.2.5 Spain Medical Disposable Products Market Size in USD million (2023-2034)
      • 7.6.2.6 Rest of Europe Medical Disposable Products Market Size in USD million (2023-2034)
    • 7.6.3 Asia-Pacific
      • 7.6.3.1 China Medical Disposable Products Market Size in USD million (2023-2034)
      • 7.6.3.2 Japan Medical Disposable Products Market Size in USD million (2023-2034)
      • 7.6.3.3 India Medical Disposable Products Market Size in USD million (2023-2034)
      • 7.6.3.4 Australia Medical Disposable Products Market Size in USD million (2023-2034)
      • 7.6.3.5 South Korea Medical Disposable Products Market Size in USD million (2023-2034)
      • 7.6.3.6 Rest of Asia-Pacific Medical Disposable Products Market Size in USD million (2023-2034)
    • 7.6.4 Rest of World
      • 7.6.4.1 Middle East Medical Disposable Products Market Size in USD million (2023-2034)
      • 7.6.4.2 Africa Medical Disposable Products Market Size in USD million (2023-2034)
      • 7.6.4.3 South America Medical Disposable Products Market Size in USD million (2023-2034)

8. Medical Disposable Products Market Competitive Landscape

  • 8.1 Market Concentration and Structure
  • 8.2 Competitive Positioning and Market Share Analysis (Premium Offering)

9. Medical Disposable Products Market Startup Funding and Investment Trends

10. Medical Disposable Products Market Company and Product Profiles

  • 10.1 Becton, Dickinson and Company (BD)
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Service Portfolio
    • 10.1.5 Strategic Initiatives / Entropy
  • 10.2 Cardinal Health
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Portfolio
    • 10.2.5 Strategic Initiatives / Entropy
  • 10.3 Medline Industries, Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Portfolio
    • 10.3.5 Strategic Initiatives / Entropy
  • 10.4 3M Company
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Portfolio
    • 10.4.5 Strategic Initiatives / Entropy
  • 10.5 Medtronic plc
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Portfolio
    • 10.5.5 Strategic Initiatives / Entropy
  • 10.6 Baxter International Inc.
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Portfolio
    • 10.6.5 Strategic Initiatives / Entropy
  • 10.7 B. Braun Melsungen AG
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Portfolio
    • 10.7.5 Strategic Initiatives / Entropy
  • 10.8 Terumo Corporation
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Portfolio
    • 10.8.5 Strategic Initiatives / Entropy
  • 10.9 Nipro Corporation
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Portfolio
    • 10.9.5 Strategic Initiatives / Entropy
  • 10.10 Molnlycke Health Care AB
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Portfolio
    • 10.10.5 Strategic Initiatives / Entropy

For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies where relevant to the market assessment.

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer and Contact Us

List of Tables

  • Table 1: Medical Disposable Products Market in Global (2023-2034)
  • Table 2: Medical Disposable Products Market in Global by Product Type (2023-2034)
  • Table 3: Medical Disposable Products Market in Global by Material (2023-2034)
  • Table 4: Medical Disposable Products Market in Global by Sterility (2023-2034)
  • Table 5: Medical Disposable Products Market in Global by Application (2023-2034)
  • Table 6: Medical Disposable Products Market in Global by End-Users (2023-2034)
  • Table 7: Medical Disposable Products Market in Global by Geography (2023-2034)
  • Table 8: Medical Disposable Products Market in North America (2023-2034)
  • Table 9: Medical Disposable Products Market in the United States (2023-2034)
  • Table 10: Medical Disposable Products Market in Canada (2023-2034)
  • Table 11: Medical Disposable Products Market in Mexico (2023-2034)
  • Table 12: Medical Disposable Products Market in Europe (2023-2034)
  • Table 13: Medical Disposable Products Market in Germany (2023-2034)
  • Table 14: Medical Disposable Products Market in United Kingdom (2023-2034)
  • Table 15: Medical Disposable Products Market in France (2023-2034)
  • Table 16: Medical Disposable Products Market in Italy (2023-2034)
  • Table 17: Medical Disposable Products Market in Spain (2023-2034)
  • Table 18: Medical Disposable Products Market in the Rest of Europe (2023-2034)
  • Table 19: Medical Disposable Products Market in Asia-Pacific (2023-2034)
  • Table 20: Medical Disposable Products Market in China (2023-2034)
  • Table 21: Medical Disposable Products Market in Japan (2023-2034)
  • Table 22: Medical Disposable Products Market in India (2023-2034)
  • Table 23: Medical Disposable Products Market in Australia (2023-2034)
  • Table 24: Medical Disposable Products Market in South Korea (2023-2034)
  • Table 25: Medical Disposable Products Market in Rest of Asia-Pacific (2023-2034)
  • Table 26: Medical Disposable Products Market in the Rest of the World (2023-2034)
  • Table 27: Medical Disposable Products Market in the Middle East (2023-2034)
  • Table 28: Medical Disposable Products Market in Africa (2023-2034)
  • Table 29: Medical Disposable Products Market in South America (2023-2034)
  • Table 30: Competitive Landscape
  • Table 31: Startup Funding and Investment Trends

List of Figures

  • Figure 1: Medical Disposable Products Market Drivers
  • Figure 2: Medical Disposable Products Market Restraints
  • Figure 3: Medical Disposable Products Market Opportunities
  • Figure 4: Impact Analysis: AI, Geopolitical, Trade, and Economic Developments
  • Figure 5: Regulatory Analysis (US, EU, Japan, China)
  • Figure 6: Porter's Five Forces Analysis
  • Figure 7: Competitive Analysis
  • Figure 8: Medical Disposable Products Market in Global (2023-2034)
  • Figure 9: Medical Disposable Products Market in Global by Product Type (2023-2034)
  • Figure 10: Medical Disposable Products Market in Global by Material (2023-2034)
  • Figure 11: Medical Disposable Products Market in Global by Sterility (2023-2034)
  • Figure 12: Medical Disposable Products Market in Global by Application (2023-2034)
  • Figure 13: Medical Disposable Products Market in Global by End-Users (2023-2034)
  • Figure 14: Medical Disposable Products Market in Global by Geography (2023-2034)
  • Figure 15: Medical Disposable Products Market in North America (2023-2034)
  • Figure 16: Medical Disposable Products Market in the United States (2023-2034)
  • Figure 17: Medical Disposable Products Market in Canada (2023-2034)
  • Figure 18: Medical Disposable Products Market in Mexico (2023-2034)
  • Figure 19: Medical Disposable Products Market in Europe (2023-2034)
  • Figure 20: Medical Disposable Products Market in Germany (2023-2034)
  • Figure 21: Medical Disposable Products Market in United Kingdom (2023-2034)
  • Figure 22: Medical Disposable Products Market in France (2023-2034)
  • Figure 23: Medical Disposable Products Market in Italy (2023-2034)
  • Figure 24: Medical Disposable Products Market in Spain (2023-2034)
  • Figure 25: Medical Disposable Products Market in the Rest of Europe (2023-2034)
  • Figure 26: Medical Disposable Products Market in Asia-Pacific (2023-2034)
  • Figure 27: Medical Disposable Products Market in China (2023-2034)
  • Figure 28: Medical Disposable Products Market in Japan (2023-2034)
  • Figure 29: Medical Disposable Products Market in India (2023-2034)
  • Figure 30: Medical Disposable Products Market in Australia (2023-2034)
  • Figure 31: Medical Disposable Products Market in South Korea (2023-2034)
  • Figure 32: Medical Disposable Products Market in Rest of Asia-Pacific (2023-2034)
  • Figure 33: Medical Disposable Products Market in the Rest of the World (2023-2034)
  • Figure 34: Medical Disposable Products Market in the Middle East (2023-2034)
  • Figure 35: Medical Disposable Products Market in Africa (2023-2034)
  • Figure 36: Medical Disposable Products Market in South America (2023-2034)
  • Figure 37: Competitive Landscape
  • Figure 38: Startup Funding and Investment Trends